Delivery Order SPE2DB25D2207-SPE2DB25FQRUX
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,000.54 for Trulicity 1.5 mg/0.5 ml pens on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within military and federal healthcare systems, reflecting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,458.30 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order represents a non-competitive award issued under a larger contract vehicle and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. Trulicity is a prescription diabetes medication commonly used within military...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,291.68 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 25, 2025, with completion anticipated by August 26, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a branded diabetes medication commonly used in military...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $3,713.49. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was made on a competitive basis. Trulicity is a brand-name diabetes...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,628.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 4, 2025. This non-set-aside, firm fixed-price delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. Trulicity is a brand-name diabetes medication commonly used within federal healthcare systems, including military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on June 20, 2025, with completion expected by June 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly used within the military healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,121.79 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens on July 15, 2025. This firm fixed-price delivery order, designated as a non-competitive award under the company's existing indefinite delivery contract with DLA, is scheduled for completion by July 16, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,264.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through competitive procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly used within military...
- The Defense Logistics Agency awarded a delivery order valued at $2,594.55 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on September 4, 2025, with completion targeted for September 5, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and federal healthcare systems...
- The Defense Logistics Agency (DLA) awarded a $5,783.00 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens with a completion date of September 9, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will fulfill the order from its corporate office location. Trulicity is a diabetes medication...
- SPE2DB25D2207Indefinite Delivery Contract
- SPE2DB25D2207-SPE2DB25FQRUXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, valued at $1,724.06, for the supply of Trulicity 1.5 mg/0.5 mL pens on September 19, 2025, with completion scheduled for September 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized across military and federal healthcare systems to support patient treatment protocols. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, a $999.99 billion comprehensive pharmaceutical prime vendor agreement extending through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs globally. The company's significant IDC with DLA enables flexible fulfillment of pharmaceutical needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/19/25 |